華潤雙鶴(600062.SH):擬設立華潤雙鶴產業基金
格隆匯8月12日丨華潤雙鶴(600062.SH)公佈,公司擬投資設立華潤雙鶴生物醫藥產業基金(呼和浩特)投資合夥企業(有限合夥)(暫定名,以工商覈準名爲準,簡稱“華潤雙鶴產業基金”或“該基金”),基金目標募集規模爲5億元人民幣,公司及全資子公司雙鶴(北京)生物技術有限公司(簡稱“雙鶴生物”)擬以自有資金出資不超過8,700萬元人民幣,佔基金總出資額的比例不超過17.40%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.